Proton beam radiation therapy Local Planned | Adenocarcinoma of prostate Untreated | Biopsy | Gleason score
Item
1. patients who are planned to undergo local proton radiotherapy for biopsy-proven, untreated, prostate adenocarcinoma with gleason scoring.
boolean
C0436226 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C0007112 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0005558 (UMLS CUI [3])
C3203027 (UMLS CUI [4])
Digital Rectal Examination TNM clinical staging
Item
2. 1992 ajcc clinical stage t1-t3c on digital rectal exam.
boolean
C1384593 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Prostate specific antigen measurement
Item
3. psa within 4 weeks of study entry.
boolean
C0201544 (UMLS CUI [1])
Zubrod Performance Status | Life Expectancy
Item
4. zubrod performance status of 0-1 with a life expectancy of at least 10 years.
boolean
C3714786 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Hormone Therapy
Item
5. prior hormonal therapy allowed if began no more than three months prior to registration.
boolean
C0279025 (UMLS CUI [1])
Clinical Study Follow-up Adherence
Item
6. patient must be able to adhere to follow-up schedule either personally or via mail or phone.
boolean
C3274571 (UMLS CUI [1,1])
C1510802 (UMLS CUI [1,2])
Able to speak English Language | Able to read English Language | Comprehension English Language
Item
7. patient must be able to speak, read and understand english.
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0586740 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
C0233733 (UMLS CUI [3,1])
C0376245 (UMLS CUI [3,2])
Informed Consent
Item
8. patient must give informed consent.
boolean
C0021430 (UMLS CUI [1])
Adenocarcinoma Histology Different
Item
1. histology other than adenocarcinoma.
boolean
C0001418 (UMLS CUI [1,1])
C4048239 (UMLS CUI [1,2])
C1705242 (UMLS CUI [1,3])
Distant metastasis | Secondary malignant neoplasm of lymph node
Item
2. evidence of distant or nodal metastasis.
boolean
C1269798 (UMLS CUI [1])
C0686619 (UMLS CUI [2])
Radiotherapy to pelvis | Chemotherapy Pelvis
Item
3. prior pelvic radiotherapy or chemotherapy.
boolean
C1536155 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C0030797 (UMLS CUI [2,2])
Operation on prostate Radical | Operation on prostate Radical Planned
Item
4. prior or planned radical prostate surgery.
boolean
C0194790 (UMLS CUI [1,1])
C0439807 (UMLS CUI [1,2])
C0194790 (UMLS CUI [2,1])
C0439807 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
Local Therapy Prostate carcinoma
Item
5. prior local therapy for prostate cancer.
boolean
C1517925 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Malignant Neoplasms | Disease Free of | Basal cell carcinoma | Squamous cell carcinoma of skin Non-invasive
Item
6. previous and/or concurrent malignancy unless disease free for >5 years. basal cell and non-invasive squamous cell carcinoma of the skin will not exclude patient from eligibility.
boolean
C0006826 (UMLS CUI [1])
C0012634 (UMLS CUI [2,1])
C0332296 (UMLS CUI [2,2])
C0007117 (UMLS CUI [3])
C0553723 (UMLS CUI [4,1])
C0205303 (UMLS CUI [4,2])
Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis
Item
7. history of inflammatory bowel disease (e.g. crohn's disease or ulcerative colitis).
boolean
C0021390 (UMLS CUI [1])
C0010346 (UMLS CUI [2])
C0009324 (UMLS CUI [3])
Metallic device Hip Interferes with Proton Dosimetry | Metallic device Pelvis Interferes with Proton Dosimetry | Hip Prosthesis
Item
8. patients with metallic devices in the hip/pelvis (e.g. hip prostheses) that may interfere with proton dosimetry will not be eligible.
boolean
C3693688 (UMLS CUI [1,1])
C0019552 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0729603 (UMLS CUI [1,4])
C0034603 (UMLS CUI [1,5])
C3693688 (UMLS CUI [2,1])
C0030797 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C0729603 (UMLS CUI [2,4])
C0034603 (UMLS CUI [2,5])
C0019560 (UMLS CUI [3])